SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

Share Price is delayed by 15 minutes
Get Live Data
75.50    0.00 (0.00%)
Bid:
73.00
Ask:
78.00
Spread: 5.00 (6.849%)
Market Cap: £10.10m
ARC Live PriceLast checked at - London Stock Exchange

Intraday Arcontech Group Share Chart

Director/PDMR Shareholding

5 Mar 2025 16:26

RNS Number : 5198Z
Arcontech Group PLC
05 March 2025
 

ARCONTECH GROUP PLC 

("Arcontech" or the "Company")

Director/PDMR Shareholding

Arcontech (AIM: ARC), the provider of products and services for real-time financial market data processing and trading, announces today that Ben Hodges, Chief Financial Officer, purchased 6,257 ordinary shares ("Ordinary Shares") at a price of 79.90 pence per share. Following this purchase, Ben Hodges has a beneficial interest of 13,023 Ordinary Shares in the Company representing approximately 0.10% of the issued share capital.

Further information is disclosed below pursuant to Article 19(3) of the Market Abuse Regulation.

Enquiries:

Arcontech Group plc

 020 7256 2300

Geoff Wicks, Chairman and Non-Executive Director

Matthew Jeffs, Chief Executive Officer

Cavendish Capital Markets Ltd (Nomad & Broker)

Carl Holmes/Rory Sale (Corporate Finance)

Harriet Ward (Corporate Broking)

020 7220 0500

To access more information on the Group please visit:  www.arcontech.com

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ben Hodges

2. 

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Arcontech Group Plc

b)

LEI

213800O7PM9V79TP7523

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of £0.125

Identification code

ARC GB00BDBBJZ03

b)

Nature of the transactions

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

79.90 pence

 

6,257

 

d)

Aggregated information:

· Aggregated volumes

· Prices

See 4(c) above

e)

Date of the transaction

5 March 2025

f)

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQELFBEXLLBBZ
Date   Source Headline
7th Sep 20217:00 amRNSExercise of Options, Director/PDMR Shareholding
1st Sep 20214:41 pmRNSSecond Price Monitoring Extn
1st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSFinal Results
10th Aug 20217:00 amRNSNotice of Results
12th Mar 202112:16 pmRNSHolding(s) in Company
23rd Feb 20217:00 amRNSInterim Results
22nd Jan 20214:30 pmRNSIssue of Equity
16th Oct 20207:00 amRNSAgreement to upgrade longstanding Tier 1 Client
5th Oct 20203:03 pmRNSGrant of Options
2nd Oct 202011:05 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSNew client win to contribute data to Factset
29th Sep 202010:53 amRNSResult of AGM
10th Sep 20207:00 amRNSIssue of Equity & PDMR Shareholding
8th Sep 20207:00 amRNSPosting of Annual Report & Notice of AGM
2nd Sep 20207:00 amRNSFinal Results
27th Aug 20201:59 pmRNSNotice of Results
20th Jul 20207:00 amRNSBoard appointment
15th Jul 20207:00 amRNSTrading Update / Notice of Results
1st Jun 20207:00 amRNSDirectorate change & Appointment of CoSec
16th Mar 20204:40 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
5th Mar 20207:00 amRNSInterim Results
28th Feb 20203:28 pmRNSTrading Update & Notice of Results
2nd Dec 20194:20 pmRNSMichael Levy
3rd Oct 20191:28 pmRNSResult of AGM
27th Sep 20191:14 pmRNSGrant of Options
11th Sep 20197:00 amRNSHolding(s) in Company
2nd Sep 20197:00 amRNSPosting of Annual Report & Notice of AGM
22nd Aug 20197:00 amRNSFinal Results
11th Jul 20197:00 amRNSTrading Update and Notice of Results
15th May 20197:00 amRNSDirector/PDMR Shareholding
8th May 20194:21 pmRNSHolding(s) in Company
29th Mar 20192:27 pmRNSDirector/PDMR Shareholding
27th Feb 20197:00 amRNSInterim Results
4th Feb 20197:00 amRNSIncreased client uptake of Excelerator
4th Dec 20189:56 amRNSHolding(s) in Company
3rd Dec 20184:13 pmRNSGrant of Options
27th Sep 201812:20 pmRNSResult of AGM
31st Aug 20187:00 amRNSPosting of Annual Report & Notice of AGM
23rd Aug 20187:00 amRNSFinal Results
13th Jul 20182:47 pmRNSDirector/PDMR Shareholding
10th Jul 20187:00 amRNSTrading Update / Notice of Results
20th Apr 20188:30 amRNSIssue of Equity and Director / PDMR Shareholding
29th Mar 20182:02 pmRNSDirector/PDMR Shareholding
1st Mar 201811:00 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSHalf-year Report
12th Oct 20173:32 pmRNSIssue of Equity & Director/PDMR Shareholding
27th Sep 20175:23 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.